• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响大样本队列研究死亡率的因素,特别关注口服避孕药的使用。

Factors affecting mortality in a large cohort study with special reference to oral contraceptive use.

机构信息

Unit of Health Care Epidemiology, University of Oxford, Oxford, UK.

出版信息

Contraception. 2010 Sep;82(3):221-9. doi: 10.1016/j.contraception.2010.04.006. Epub 2010 May 18.

DOI:10.1016/j.contraception.2010.04.006
PMID:20705149
Abstract

BACKGROUND

This analysis updates mortality in the Oxford-Family Planning Association (Oxford-FPA) contraceptive study, with emphasis on oral contraceptive (OC) use.

STUDY DESIGN

The Oxford-FPA study includes 17,032 women recruited from 1968-1974 at contraceptive clinics, aged 25-39 years, using OCs a diaphragm or an intrauterine device. Follow-up has been to March 2009; by then, 1715 women had died.

RESULTS

The rate ratio (RR) for overall mortality was 0.87 (CI 0.79-0.96), comparing ever-users of OCs with never-users. The RR for fatal cervical cancer was increased (7.3), but the CIs were very wide (1.2-305). There was no association between ever-use of OCs and mortality from breast cancer (RR 1.0, CI 0.8-1.2), nor was fatal breast cancer related to duration of OC use. OC use strongly protected against death from other uterine cancer and ovarian cancer; RRs for ever-use of OCs were 0.3 (CI 0.1-0.8) and 0.4 (CI 0.3-0.6), respectively. Protection increased with duration of OC use and persisted more than 20 years after cessation. Circulatory disease mortality was not increased, the RR for ever-use of OCs being 0.9 (CI 0.7-1.1). The overall mortality RR for all women smoking 15+ cigarettes daily was 2.25 (CI 1.99-2.53) and, for all women with a body mass index of 28+ kg/m(2), was 1.33 (CI 1.07-1.64).

CONCLUSIONS

Long-term follow-up strongly suggests that OC use slightly reduces all cause mortality.

摘要

背景

本分析更新了牛津计划生育协会(Oxford-FPA)避孕研究中的死亡率,重点关注口服避孕药(OC)的使用。

研究设计

牛津-FPA 研究包括 1968 年至 1974 年在避孕诊所招募的 17032 名年龄在 25-39 岁的女性,她们使用 OCs、隔膜或宫内节育器。随访至 2009 年 3 月;截至那时,已有 1715 名女性死亡。

结果

与从未使用过 OCs 的女性相比,OC 使用者的总死亡率比为 0.87(CI 0.79-0.96)。致命宫颈癌的风险比(RR)增加(7.3),但 CI 非常宽(1.2-305)。OC 使用与乳腺癌死亡率之间没有关联(RR 1.0,CI 0.8-1.2),也与 OC 使用时间无关。OC 使用可强烈预防其他子宫癌和卵巢癌的死亡;OC 使用者的 RR 分别为 0.3(CI 0.1-0.8)和 0.4(CI 0.3-0.6)。保护作用随 OC 使用时间的延长而增加,并在停药 20 多年后仍持续存在。循环系统疾病死亡率没有增加,OC 使用者的 RR 为 0.9(CI 0.7-1.1)。每天吸烟 15 支以上的所有女性的总死亡率 RR 为 2.25(CI 1.99-2.53),所有 BMI 为 28kg/m² 以上的女性的 RR 为 1.33(CI 1.07-1.64)。

结论

长期随访强烈表明,OC 使用略微降低了所有原因的死亡率。

相似文献

1
Factors affecting mortality in a large cohort study with special reference to oral contraceptive use.影响大样本队列研究死亡率的因素,特别关注口服避孕药的使用。
Contraception. 2010 Sep;82(3):221-9. doi: 10.1016/j.contraception.2010.04.006. Epub 2010 May 18.
2
The Oxford-Family Planning Association contraceptive study.牛津计划生育协会避孕研究。
Clin Obstet Gynaecol. 1984 Dec;11(3):743-57.
3
Hormonal contraceptive methods.激素避孕方法。
Practitioner. 1985 May;229(1403):415-23.
4
Ensuring the future of family planning: the move toward excellence in contraceptive research.确保计划生育的未来:迈向卓越的避孕研究
Obstet Gynecol. 2007 Jun;109(6):1266-7. doi: 10.1097/01.AOG.0000267115.59222.d6.
5
The use of oral contraceptives by adolescents for contraception, menstrual cycle problems or acne.青少年使用口服避孕药来避孕、解决月经周期问题或治疗痤疮。
Acta Obstet Gynecol Scand. 1998 Oct;77(9):898-904.
6
Oral contraceptives: the risks in perspective.口服避孕药:风险透视
Nurse Pract. 1984 Sep;9(9):25-6, 28-9, 62.
7
[Contraception and family planning].[避孕与计划生育]
Z Arztl Fortbild (Jena). 1977 Nov 15;71(22):1041-5.
8
Contraception by age group.按年龄组划分的避孕情况。
Practitioner. 1988 Jan;232(1441):15-20.
9
[Recent advances in contraception and family planning].[避孕与计划生育的最新进展]
Salud Publica Mex. 1992 Jan-Feb;34(1):5-17.
10
[Contraception in adolescents].[青少年避孕]
Z Arztl Fortbild (Jena). 1988;82(3):115-9.

引用本文的文献

1
Assessing the impact of contraceptive use on reproductive cancer risk among women of reproductive age-a systematic review.评估避孕措施对育龄妇女患生殖系统癌症风险的影响——一项系统综述
Front Glob Womens Health. 2024 Nov 13;5:1487820. doi: 10.3389/fgwh.2024.1487820. eCollection 2024.
2
The impact of female sex hormones on cardiovascular disease: from mechanisms to hormone therapy.女性性激素对心血管疾病的影响:从机制到激素治疗
J Geriatr Cardiol. 2024 Jun 28;21(6):669-681. doi: 10.26599/1671-5411.2024.06.003.
3
Associations of Oral Contraceptive Use With Cardiovascular Disease and All-Cause Death: Evidence From the UK Biobank Cohort Study.
口服避孕药使用与心血管疾病和全因死亡的关联:来自英国生物库队列研究的证据。
J Am Heart Assoc. 2023 Aug 15;12(16):e030105. doi: 10.1161/JAHA.123.030105. Epub 2023 Aug 10.
4
Examining the relation between oral contraceptive use and attentional engagement in everyday life.研究口服避孕药的使用与日常生活中注意力投入之间的关系。
Front Hum Neurosci. 2023 Jun 1;17:1147515. doi: 10.3389/fnhum.2023.1147515. eCollection 2023.
5
The correlation between women's various gynaecological diseases to ovarian cancer in Sulaimaniyah City, Iraq.伊拉克苏莱曼尼亚市女性各种妇科疾病与卵巢癌的相关性。
J Int Med Res. 2023 Apr;51(4):3000605231158949. doi: 10.1177/03000605231158949.
6
Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk.重新评估激素避孕与乳腺癌风险之间的关联。
Breast Cancer (Dove Med Press). 2023 Mar 22;15:227-235. doi: 10.2147/BCTT.S390664. eCollection 2023.
7
Review of the literature on combined oral contraceptives and cancer.关于复方口服避孕药与癌症的文献综述。
Ecancermedicalscience. 2022 Jun 23;16:1416. doi: 10.3332/ecancer.2022.1416. eCollection 2022.
8
Medical Eligibility for Contraception in Women at Increased Risk.《增加妊娠风险妇女避孕方法医学咨询服务技术指南》
Dtsch Arztebl Int. 2019 Nov 8;116(45):764-774. doi: 10.3238/arztebl.2019.0764.
9
A prospective investigation of oral contraceptive use and breast cancer mortality: findings from the Swedish women's lifestyle and health cohort.口服避孕药使用与乳腺癌死亡率的前瞻性研究:来自瑞典女性生活方式与健康队列的研究结果。
BMC Cancer. 2019 Aug 14;19(1):807. doi: 10.1186/s12885-019-5985-6.
10
Reducing the Risk of Gynecologic Cancer in Hereditary Breast Ovarian Cancer Syndrome Mutation Carriers: Moral Dilemmas and the Principle of Double Effect.降低遗传性乳腺癌卵巢癌综合征突变携带者患妇科癌症的风险:道德困境与双重效应原则
Linacre Q. 2018 Aug;85(3):225-240. doi: 10.1177/0024363918788340. Epub 2018 Jul 20.